SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001557142-19-000079
Filing Date
2019-11-07
Accepted
2019-11-07 16:32:08
Documents
85
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kdmn-20190930x10q.htm 10-Q 1578152
2 EX-10.1 kdmn-20190930xex10_1.htm EX-10.1 78536
3 EX-10.2 kdmn-20190930xex10_2.htm EX-10.2 91118
4 EX-31.1 kdmn-20190930xex31_1.htm EX-31.1 20179
5 EX-31.2 kdmn-20190930xex31_2.htm EX-31.2 20272
6 EX-32.1 kdmn-20190930xex32_1.htm EX-32.1 10313
7 EX-32.2 kdmn-20190930xex32_2.htm EX-32.2 10151
  Complete submission text file 0001557142-19-000079.txt   7237002

Data Files

Seq Description Document Type Size
8 EX-101.INS kdmn-20190930.xml EX-101.INS 1421921
9 EX-101.SCH kdmn-20190930.xsd EX-101.SCH 56153
10 EX-101.CAL kdmn-20190930_cal.xml EX-101.CAL 69791
11 EX-101.DEF kdmn-20190930_def.xml EX-101.DEF 257127
12 EX-101.LAB kdmn-20190930_lab.xml EX-101.LAB 464550
13 EX-101.PRE kdmn-20190930_pre.xml EX-101.PRE 426200
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 212-308-6000
Kadmon Holdings, Inc. (Filer) CIK: 0001557142 (see all company filings)

IRS No.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37841 | Film No.: 191200841
SIC: 2834 Pharmaceutical Preparations